Conditional disease‐free survival rates and their associated determinants in patients with epithelial ovarian cancer: A 15‐year retrospective cohort study-Reference-Cited by-同舟云学术

Conditional disease‐free survival rates and their associated determinants in patients with epithelial ovarian cancer: A 15‐year retrospective cohort study

Published:2021-05-05 Issue:6 Volume:4 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Ebrahimi Vahid¹,Khalafi‐Nezhad Abolfazl²,Ahmadpour Fatemeh³,Jowkar Zahra⁴

Affiliation:

1. Department of Biostatistics, School of Medicine Shiraz University of Medical Sciences Shiraz Iran

2. Department of Hematology, Medical Oncology and Stem Cell Transplantation School of Medicine, Shiraz University of Medical Sciences Shiraz Iran

3. Department of Obstetrics and Gynecology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran

4. Oral and Dental Disease Research Center, Department of Operative Dentistry, School of Dentistry Shiraz University of Medical Sciences Shiraz Iran

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1416

Reference32 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Parity as a Prognostic Factor in Patients with Advanced-Stage Epithelial Ovarian Cancer

3. Overall survival and post-progression survival are potent endpoint in phase III trials of second/third-line chemotherapy for advanced or recurrent epithelial ovarian cancer

4. Factors influencing survival time of hemodialysis patients; time to event analysis using parametric models: a cohort study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis and conditional survival among women with newly diagnosed ovarian cancer;Gynecologic Oncology;2024-01

2. Efficacy and Safety of Paclitaxel and Carboplatin for Platinum-Sensitive Ovarian Cancer: A Systematic Review and Meta-Analysis;Journal of Clinical Pharmacy and Therapeutics;2023-06-05

3. The Significance of Radiotherapy in Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis;Cancer Control;2023-04

4. Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer;Biomedicines;2021-12-31